Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Drug resistance in non-subtype B HIV-1.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology - 1 Mar 2004

Kantor Rami, Katzenstein David

Abstract excerpt

Treatment of HIV-1 with antiretroviral therapy may select mutations in the pol gene associated with resistance to reverse transcriptase inhibitors and protease inhibitors. To provide durable clinical benefit, emergence of drug resistance is countered by prescription of alternative drug regimens. Data on sequential treatments that are effective after virologic failure and the selection of drug resistance is...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to HIV Protease
Share to HIV Protease Inhibitors
Share to HIV Reverse Transcriptase

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Drug Resistance, Viral

Share to Drug Therapy, Combination

Share to HIV Infections

Share to Anti-HIV Agents

Share to Reverse Transcriptase Inhibitors

Source

Identifiers

PMID: 14962783
DOI: 10.1016/S1386-6532(03)00115-X

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Drug resistance in non-subtype B HIV-1.PMID 14962783Read ↗

Drug resistance in non-B subtype HIV-1: impact of HIV-1 reverse transcriptase inhibitors.Semantic proximity Read ↗

Transmitted Drug Resistance in Nonsubtype B HIV-1 InfectionSemantic proximity Read ↗

Role of HIV Subtype Diversity in the Development of Resistance to Antiviral DrugsSemantic proximity Read ↗

Genotypic resistance tests for the management of the HIV-infected patient with non-B viral isolates.Semantic proximity Read ↗

Do HIV-1 non-B subtypes differentially impact resistance mutations and clinical disease progression in treated populations? Evidence from a systematic review.Semantic proximity Read ↗

HIV Genetic Diversity and Drug ResistanceSemantic proximity Read ↗

New antiretroviral inhibitors and HIV-1 drug resistance: more focus on 90% HIV-1 isolates?Semantic proximity Read ↗

Prevalence of Drug‐Resistant HIV‐1 Variants in Untreated Individuals in Europe: Implications for Clinical ManagementSemantic proximity Read ↗

HIV type-1 drug resistance in antiretroviral treatment-naive adults infected with non-B subtype virus in the United Kingdom.Semantic proximity Read ↗

Impact of HIV-1 pol diversity on drug resistance and its clinical implications.Semantic proximity Read ↗

Increasing prevalence of transmitted drug resistance mutations and non-B subtype circulation in antiretroviral-naive chronically HIV-infected patients from 2001 to 2006/2007 in France.Semantic proximity Read ↗

HIV-1 Genetic Variability and Clinical ImplicationsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.